BHVN BHVN R2K
$11.01
-25.66% 1Y
Market & Price
Market Cap
-
Current Price
$11.01
High / Low (52W)
$18.11 / $7.79
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-0.88
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$451.45M
Current Assets
$368.33M
Working Capital
$252.40M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
-
Profit 5Y
-9.85%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
No notable strengths flagged.
CONS
- Earnings shrank at -9.9% CAGR over 5 years.
- Trading 39.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 221.56M | 211.70M | 169.38M | 142.73M | 130.43M |
| Operating Income | - | - | -55.49M | -89.77M | -197.11M | -67.64M | -77.78M | -94.01M | -110.55M | -183.24M | -333.77M | -178.17M | -221.56M | -211.70M | -169.38M | -142.73M | -130.43M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | -219.31M | -209.72M | -166.26M | -140.16M | -128.06M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | -221.07M | -197.89M | -173.22M | -145.20M | -130.26M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | 609.00K | 261.00K | 221.00K | 351.00K | 272.00K |
| Net Income | -62.12M | -45.42M | -54.37M | -97.03M | -203.29M | -68.85M | -70.49M | -90.35M | -102.57M | -179.50M | -319.77M | -160.30M | -221.68M | -198.15M | -173.44M | -145.56M | -130.53M |
| Diluted EPS | - | - | -1.38 | -2.46 | -5.16 | -1.75 | -1.03 | -1.32 | -1.50 | -2.20 | -3.64 | -1.70 | -2.17 | -1.94 | -1.64 | -1.21 | -0.88 |
| R&D Expense | - | - | 46.97M | 70.10M | 177.09M | 52.84M | 63.46M | 79.49M | 95.52M | 155.97M | 314.82M | 157.61M | 187.58M | 184.37M | 141.17M | - | 103.83M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | 567.93M | 436.05M | 885.11M | 745.38M |
| Operating Income | -114.51M | - | -567.93M | -436.05M | -885.11M | -745.38M |
| EBITDA | - | - | -566.55M | -429.14M | -877.26M | -735.46M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | - | -569.84M | -409.55M | -845.69M | -737.38M |
| Tax Provision | - | - | 438.00K | -1.38M | 735.00K | 1.44M |
| Net Income | -118.67M | - | -570.28M | -408.17M | -846.42M | -738.82M |
| Diluted EPS | -3.01 | -5.97 | -12.75 | -5.73 | -9.28 | - |
| R&D Expense | 98.46M | 181.49M | 437.07M | 373.28M | 795.87M | 635.07M |
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -9.85% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -25.66% |
| 6 Months: | +17.00% |
| 3 Months: | -4.43% |
| 1 Month: | +19.67% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | - | - | 661.78M | 513.21M | 615.11M | 451.45M |
| Current Assets | - | - | - | 586.97M | 442.45M | 538.47M | 368.33M |
| Cash & Equivalents | - | 82.51M | - | 204.88M | 248.40M | 99.13M | 229.96M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | 9.91M | 46.14M | 13.25M | 2.60M | - |
| Total Liabilities | - | - | - | 123.01M | 85.24M | 191.67M | 399.38M |
| Current Liabilities | - | - | - | 90.02M | 55.42M | 154.23M | 115.93M |
| Long Term Debt | - | - | - | - | - | - | 238.90M |
| Total Debt | - | - | - | 33.60M | 30.88M | 36.58M | 284.61M |
| Total Equity | 14.45M | 16.78M | - | 538.77M | 427.98M | 423.44M | 52.07M |
| Shares Outstanding | - | - | - | 68.19M | 81.12M | 101.22M | 132.78M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -75.96M | - | -297.69M | -331.73M | -582.45M | -609.44M |
| Investing Cash Flow | -2.70M | - | -304.79M | 129.83M | -244.97M | 300.56M |
| Financing Cash Flow | 152.24M | - | 767.60M | 211.91M | 677.77M | 439.12M |
| Capital Expenditure | -1.10M | - | -41.07M | -3.05M | -4.05M | -715.00K |
| Free Cash Flow | -77.05M | - | -338.76M | -334.77M | -586.50M | -610.15M |
| Net Change in Cash | - | - | 165.12M | 10.01M | -149.65M | 130.24M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | -707.2% | - | -105.8% | -95.4% | -199.9% | -1,418.8% |
| ROCE % | - | - | -99.3% | -95.3% | -192.0% | -222.2% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BHVN
No recent headlines available.